COMPARATIVE STUDY
EVALUATION STUDY
JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Longitudinal evaluation of supervised versus unsupervised exercise programs for the treatment of osteoporosis.

The efficacy of an exercise program was investigated in a study of 89 post-menopausal women with osteoporosis over a 5-year follow-up period. The study attempted to examine and compare potential differences in bone mineral density (BMD), incidence of fracture, and loss of height, between a group of patients (n = 42) who attended the supervised exercise program in the hospital, and a group (n = 47) who exercised at home. Habitual physical activity, as estimated using the Harvard Alumni Questionnaire, and a Physical Activity Index were combined to obtain an estimate of overall weekly caloric expenditure over the 5-year period. The exercise program involved weight-bearing aerobic activities of moderate intensity, and muscle strengthening exercise using free weights. The mean percentage change for the lumbar BMD was + 4.4% in the hospital group and +3.4% in the home group while for the femoral neck BMD was + 1.1% in the hospital group and -0.9% in the home group. There was a significant reduction in the number of fractures and no significant loss of height over the 5-year follow-up period for both groups. As the correlation between BMD and weekly caloric expenditure of the subjects was not significant, no conclusion can be drawn as to the minimum level of caloric expenditure necessary in order to retard bone loss. It was concluded that for the post-menopausal women with osteoporosis who participated in the program it was possible to stabilize their height and the BMD of the lumbar site, and to reduce fractures over the 5-year study period regardless if they exercised in a supervised or in an unsupervised setting.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app